A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD2.74
- USD2.75
- USD2.68
- USD3.29
- 10.00%
- 24M
- 195.44k
- 2.30M
- 490M
- 1.69
- -4.80%
Stock News
3 hours ago
Anglo American does not find BHP $39 billion offer attractive, sources say
Yahoo
4 hours ago
CEOs are quitting at record rates, and women are twice as likely as men to leave
CNBC
4 hours ago
Stocks are tumbling. But these 2 portfolio holdings should be defying the slide
CNBC
4 hours ago
Schneider Electric Releases All-In-One Battery Energy Storage System for Microgrids
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
